-
RepliCel Life Sciences Inc. (OTCBB:REPCF), Vancouver, B.C. Product: Autologous dermal sheath cup cells (DSCC) Business: Dermatology Molecular target: NA Description: Dermal sheath cup cells (DSCC) isolated from a …
Published on 5/21/2012
-
Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Product: Blinatumomab (AMG 103) (formerly MT103) Business: Cancer Molecular target: CD19 Description: Bispecific T cell engager (BiTE) against CD19 Indication: Treat acute…
Published on 5/21/2012
-
Exelixis Inc. (NASDAQ:EXEL), South San Francisco, Calif. Product: Cabozantinib (XL184) Business: Cancer Molecular target: Vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) (VEGFR-2); c-Met receptor …
Published on 5/21/2012
-
S.L.A. Pharma AG, Liestal, Switzerland Ventrus Biosciences Inc. (NASDAQ:VTUS), New York, N.Y. Product: Diltiazem cream (VEN 307) Business: Gastrointestinal Molecular target: NA Description: Topical formulation of …
Published on 5/21/2012
-
Elevation Pharmaceuticals Inc., San Diego, Calif. Product: EP-101 Business: Pulmonary Molecular target: Muscarinic receptor Description: Inhaled formulation of glycopyrrolate, a long-acting muscarinic antagonist (LAMA) …
Published on 5/21/2012
-
Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. Merck KGaA (Xetra:MRK), Darmstadt, Germany Product: Erbitux cetuximab Business: Cancer Molecular target: Epidermal …
Published on 5/21/2012
-
NeuroSigma Inc., Los Angeles, Calif. Product: External Trigeminal Nerve Stimulation (eTNS) Business: Neurology Molecular target: NA Description: Trigeminal nerve stimulation system utilizing external electrodes and a …
Published on 5/21/2012
-
Mucosis B.V., Groningen, the Netherlands Product: FluGEM Business: Infectious Molecular target: NA Description: Mucosal-based influenza vaccine using Mimopath technology containing bacterium-like particles (BLPs) and …
Published on 5/21/2012
-
Galleon Pharmaceuticals Inc., Newtown, Pa. Product: GAL-021 Business: Pulmonary Molecular target: NA Description: Undisclosed small molecule designed to support respiratory drive in surgical and critical care patients …
Published on 5/21/2012
-
Genfit S.A. (Euronext:ALGFT), Lille, France Product: GFT505 Business: Hepatic Molecular target: Peroxisome proliferation activated receptor (PPAR) Description: Dual peroxisome proliferation activated receptor (PPAR) …
Published on 5/21/2012
-
Trovagene Inc. (Pink:TROV), San Diego, Calif. Product: HPV assay Business: Diagnostic Molecular target: NA Description: Urine-based HPV detection assay Indication: Detect high-risk HPV subtypes from urine specimens …
Published on 5/21/2012
-
Theraclone Sciences Inc., Seattle, Wash. Zenyaku Kogyo Co. Ltd., Tokyo, Japan Product: Human anti-M2e antibody (TCN-032) Business: Infectious Molecular target: Influenza A virus matrix protein M2 (M2) Description: Human…
Published on 5/21/2012
-
Idera Pharmaceuticals Inc. (NASDAQ:IDRA), Cambridge, Mass. Product: IMO-2055, EMD 1201081 Business: Cancer Molecular target: Toll-like receptor 9 (TLR9) Description: Second-generation synthetic immune modulatory …
Published on 5/21/2012
-
Lightlake Therapeutics Inc. (OTCBB:LLTP), London, U.K. Product: Intranasal naloxone Business: Neurology Molecular target: NA Description: Opioid antagonist nasal spray Indication: Treat binge eating disorder Endpoint: …
Published on 5/21/2012
-
H. Lundbeck A/S (CSE:LUN), Copenhagen, Denmark Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Product: Lu AA21004 Business: Neurology Molecular target: Serotonin (5-HT3) receptor; Serotonin (5-HT1A) receptor …
Published on 5/21/2012
-
H. Lundbeck A/S (CSE:LUN), Copenhagen, Denmark Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Product: Lu AA21004 Business: Neurology Molecular target: Serotonin (5-HT3) receptor; Serotonin (5-HT1A) receptor …
Published on 5/21/2012
-
H. Lundbeck A/S (CSE:LUN), Copenhagen, Denmark Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Product: Lu AA21004 Business: Neurology Molecular target: Serotonin (5-HT3) receptor; Serotonin (5-HT1A) receptor …
Published on 5/21/2012
-
Isconova AB (SSE:ISCO), Uppsala, Sweden Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Product: Matrix M adjuvant Business: Infectious Molecular target: NA Description: Vaccine adjuvant Indication: Prevent seasonal …
Published on 5/21/2012
-
Gilead Sciences Inc. (NASDAQ:GILD), Foster City, Calif. MicroDose Therapeutx Inc., Monmouth Junction, N.J. Product: MDT-637 Business: Infectious Molecular target: NA Description: Inhalable small molecule antiviral …
Published on 5/21/2012
-
Gilead Sciences Inc. (NASDAQ:GILD), Foster City, Calif. MicroDose Therapeutx Inc., Monmouth Junction, N.J. Product: MDT-637 Business: Infectious Molecular target: NA Description: Inhalable small molecule antiviral …
Published on 5/21/2012
-
Array BioPharma Inc. (NASDAQ:ARRY), Boulder, Colo. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Product: MEK162 (formerly ARRY-162) Business: Cancer Molecular target: MEK Description: Oral MEK inhibitor …
Published on 5/21/2012
-
Mologen AG (Xetra:MGN), Berlin, Germany Product: MGN1703 Business: Cancer Molecular target: Toll-like receptor 9 (TLR9) Description: Toll-like receptor 9 (TLR9) agonist based on double Stem Loop Immunomodulator (dSLIM) …
Published on 5/21/2012
-
Midatech Ltd., Abingdon, U.K. MonoSol Rx LLC, Warren, N.J. Product: Midaform Insulin PharmFilm, Transbuccal Insulin PharmaFilm Business: Endocrine/Metabolic Molecular target: NA Description: Oral film formulation of …
Published on 5/21/2012
-
S.L.A. Pharma AG, Liestal, Switzerland Product: Nalcol naloxone Business: Gastrointestinal Molecular target: NA Description: Slow-release, oral formulation of naloxone Indication: Treat opioid-induced constipation (OIC)…
Published on 5/21/2012
-
Ono Pharmaceutical Co. Ltd. (Tokyo:4528; Osaka:4528), Osaka, Japan Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. Product: ONO-4538, MDX-1106, BMS-936558 Business: Cancer Molecular target: PD-1 receptor (PDCD1) (PD…
Published on 5/21/2012